The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes
Abstract
Despite the previous description of the leukocyte differentiation antigen CD20 as B cell restricted, the findings reported here indicate that a small subset of human T cells expresses low levels of CD20 or a cross‐reacting antigen. Three different CD20 monoclonal antibodies (mAb), Leu16, B1, and 1F5, reacted with the T cell subset. B cells that expressed CD20 were CD20 bright and constituted an average of 9.2 ± 3.3% of adult PBL. Meanwhile, T cells that expressed CD20 were CD20 dim and represented 2.4 ± 1.5% of the PBL. This population may have been overlooked in previous studies due to the low level of CD20 expression per T cell and the small size of the subset in most individuals. Blocking studies indicated that CD20 mAb binding to CD3+ cells was due to the antigen‐reactive regions of the CD20 antibodies and was not a result of Fc receptor binding, or non‐specific fluorochrome or protein binding. The T cell nature of the CD20 dim CD3+ cells was confirmed by the rapid rise in the intracellular calcium concentration ([Ca 2+]i) of CD20 dim cells observed following treatment with CD3 mAb but not following treatment with anti‐human immunoglobulin (Ig). Extensive three‐color immunophenotypic analyses indicated that CD20 dim T cells were phenotypically heterogeneous and displayed a leukocyte differentiation profile that was slightly different than that of CD20− T cells. Thus, the CD20 dim T cells were more likely than CD20− T cells to be γ/δ T cell antigen receptor positive (14% vs. 3.4%), CD8+ (57% vs. 33%), and CD45RO+ (82% vs. 51%); fewer were CD38+ (5% vs. 24%) or CD4+ (35% vs. 61%). Given that most differentiation antigens expressed on leukocytes participate in the functions of the cells that express them, it is possible that CD20 plays a role on the T cells on which it is expressed, although the function(s) of the CD20 molecule on T and B cells remains unknown. © 1993 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jackson, D. G., & Bell, J. I. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2811 · Cited by 343
Cited by
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Leandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
From the bench to the bedside: ways to improve rituximab efficacy
Cartron, G., Watier, H., Golay, J., & Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2004-03-1110 · Cited by 523
Metadata
- Authors
- Hultin, L. E., Hausner, M. A., Hultin, P. M., & Giorgi, J. V.
- Venue
- Cytometry
- Publisher
- Wiley
- Published
- 1993-01
- Volume
- 14
- Issue
- 2
- Pages
- 196-204
- ISSN
- 0196-4763 (ISSN-L)
- 1097-0320
- OpenAlex
- W1966279605
- Cited by
- 204
- References
- 1
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. https://app.cochat.ai/papers/10.1002/cyto.990140212
- The paper
- Hultin, L. E., Hausner, M. A., Hultin, P. M., & Giorgi, J. V. (1993). Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry. https://doi.org/10.1002/cyto.990140212
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.